The Federal Trade Commission (FTC) and a coalition of seven states filed a request in a federal court on Tuesday to hold Martin Shkreli in contempt for allegedly violating a lifetime ban from participating in the pharmaceutical industry. The court filing was submitted to the U.S. District Court for the Southern District of New York, where the FTC stated that Shkreli has been 'flagrantly and repeatedly' disregarding the ban.
✓ AI-Debiased Article
30
Mainstream framing
provisional
Why this rating? · 1 signal
Signals flagged in the original
- headline asserts a conclusion / scare-quotes
Provisional estimate — refines shortly Full breakdown ↓
FTC Requests Court Action Against Martin Shkreli for Violating Industry Ban
The FTC, along with seven states, has requested that a federal court hold Martin Shkreli in contempt for violating a lifetime ban from the pharmaceutical industry. The filing was made in the U.S. District Court for the Southern District of New York.
People
Martin Shkreli
Annotating as
No note attached
on this article.
Language Analysis
Loaded-language score
30/100
wirepublicmainstream
flavoredpartisanadvocacy
Inflammatory language
10/100
Sentiment
-100/100
Loaded Language Removed
- ✕ headline asserts a conclusion / scare-quotes
Original vs. Neutral
Original Headline
FTC: ‘Pharma bro’ Shkreli violated lifetime industry ban, should be held in contempt
Neutral Headline
FTC Requests Court Action Against Martin Shkreli for Violating Industry Ban